Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Messengers: fibroblast growth factor 15/19
Raffaella Maria Gadaleta, Antonio Moschetta
Nature Metabolism (2019) Vol. 1, Iss. 6, pp. 588-594
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Gut-liver axis: Pathophysiological concepts and clinical implications
Herbert Tilg, Timon E. Adolph, Michael Trauner
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1700-1718
Open Access | Times Cited: 371
Bile acids and their receptors in metabolic disorders
Stefano Fiorucci, Eleonora Distrutti, Adriana Carino, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101094-101094
Closed Access | Times Cited: 175
The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration
Mariya Farooq, Abdul Waheed Khan, Moon Suk Kim, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3242-3242
Open Access | Times Cited: 150
Current therapies and new developments in NASH
Jean‐François Dufour, Quentin M. Anstee, Elisabetta Bugianesi, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2123-2134
Open Access | Times Cited: 149
Metabolic Messengers: bile acids
Alessia Perino, Kristina Schoonjans
Nature Metabolism (2022) Vol. 4, Iss. 4, pp. 416-423
Closed Access | Times Cited: 126
FXR in liver physiology: Multiple faces to regulate liver metabolism
Katrin Panzitt, Martin Wagner
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 7, pp. 166133-166133
Open Access | Times Cited: 112
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 98
Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
Lucilla Crudele, Raffaella Maria Gadaleta, Marica Cariello, et al.
EBioMedicine (2023) Vol. 97, pp. 104821-104821
Open Access | Times Cited: 97
FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
Meng Xie, Zhuoying Lin, Xiaoyu Ji, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 109-125
Open Access | Times Cited: 95
Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease
Chuyun Yan, Wanting Hu, Jinqi Tu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 59
Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases
Xiaokun Li, Weiqin Lu, Alexei Kharitonenkov, et al.
Journal of Internal Medicine (2024) Vol. 295, Iss. 3, pp. 292-312
Open Access | Times Cited: 24
Adipokines: masterminds of metabolic inflammation
Herbert Tilg, Gianluca Ianiro, Antonio Gasbarrini, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 22
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
Raffaella Maria Gadaleta, Oihane García‐Irigoyen, Marica Cariello, et al.
EBioMedicine (2020) Vol. 54, pp. 102719-102719
Open Access | Times Cited: 86
Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
Yixuan Qiu, Jiaming Yu, Yi Li, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 508-522
Open Access | Times Cited: 72
Diet and feeding pattern modulate diurnal dynamics of the ileal microbiome and transcriptome
Ana Carolina Dantas Machado, Steven D. Brown, Amulya Lingaraju, et al.
Cell Reports (2022) Vol. 40, Iss. 1, pp. 111008-111008
Open Access | Times Cited: 62
Recent advances on FXR-targeting therapeutics
Katrin Panzitt, Gernot Zollner, Hanns‐Ulrich Marschall, et al.
Molecular and Cellular Endocrinology (2022) Vol. 552, pp. 111678-111678
Open Access | Times Cited: 53
Fibroblast Growth Factor–Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications
Leigang Jin, Ranyao Yang, Leiluo Geng, et al.
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 359-382
Open Access | Times Cited: 43
Roles of bile acids signaling in neuromodulation under physiological and pathological conditions
Xing Chen, Xin Huang, Dongxue Wang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Rong Cao, Huimin Tian, Yu Zhang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 27
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases
Luyao Shen, Yongsheng Li, Huakan Zhao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Progress in Biomarkers Related to Biliary Atresia
Fanyang Kong, Rui Dong, Gong Chen, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 11
Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota
Lijuan Zhao, Hong‐Xiang Lou, Ying Peng, et al.
Diabetes Research and Clinical Practice (2020) Vol. 169, pp. 108418-108418
Closed Access | Times Cited: 70
Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A
Young‐Chae Kim, Sunmi Seok, Yang Zhang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 54
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, et al.
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100284-100284
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top